AbbVie Inc. against EssilorLuxottica Société anonyme — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:50+00:00 UTC · updates daily
ABBV leads 3 of the 5 windows we measure — over 1 month ABBV is +0.2% and EL.PA -7.3%; over year to date ABBV is +16.0% and EL.PA -44.4%.
| ABBV | EL.PA | |
|---|---|---|
| Price | $265.08 | $149.95 |
| 1 day | -0.1% | +3.8%lead |
| 5 days | +1.0% | +3.3%lead |
| 1 month | +0.2%lead | -7.3% |
| 6 months | +29.4%lead | -22.3% |
| Year to date | +16.0%lead | -44.4% |
| 52-week position | 95% of range | 6% of range |
| 52-week range | $190.75–$269.39 | $138.30–$323.80 |
| vs 50-day average | above $256.43 | below $159.21 |
| vs 200-day average | above $230.16 | below $199.87 |
| RSI (14) | 55 | 45 |
| Next earnings | 2026-10-29 | 2026-02-11 |
ABBV trades at $265.08, above its 50-day average of $256.43, and above the 200-day at $230.16. It sits at 95% of its 52-week range ($190.75–$269.39); 14-day RSI is 55, in neutral territory; an average session moves it about 2.1%. For levels, the first level overhead is $265.97 (0.3% away) and the first support below is $262.28 (1.1% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
EL.PA trades at $149.95, below its 50-day average of $159.21, and below the 200-day at $199.87. It sits at 6% of its 52-week range ($138.30–$323.80); 14-day RSI is 45, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $150.00 (0.0% away) and the first support below is $139.00 (7.3% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
EL.PA is the more volatile of the two — an average session moves it 2.6% against 2.1% for ABBV, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: ABBV clearing $265.97 or losing $262.28; EL.PA clearing $150.00 or losing $139.00. Until one of them gives way, the relative reading above stands.